+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A Comparison of Dosimetric Parameters in PET-Based Active Bone Marrow Volume and Total Bone Volume in Prediction of Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiation



A Comparison of Dosimetric Parameters in PET-Based Active Bone Marrow Volume and Total Bone Volume in Prediction of Hematologic Toxicity in Cervical Cancer Patients Treated with Chemoradiation



International Journal of Radiation Oncology*biology*physics 96(2): E307-E308




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064797336

Download citation: RISBibTeXText

DOI: 10.1016/j.ijrobp.2016.06.1399


Related references

The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation. Clinical and Translational Oncology 20(6): 713-718, 2017

Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy. International Journal of Gynecological Cancer 24(9): 1648-1652, 2015

Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Locally Advanced Rectal Cancer Patients Treated with Concurrent Weekly Irinotecan in Combination with Capecitabine-Based Chemoradiotherapy and Neoadjuvant Imrt. International Journal of Radiation Oncology*Biology*Physics 102(3): e24-e25, 2018

The Volume of Pet-Defined, Active Bone Marrow Spared Predicts Acute Hematologic Toxicities in Anal Cancer Patients Receiving Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics 99(2): E148-E149, 2017

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. International Journal of Radiation Oncology, Biology, Physics 70(5): 1431-1437, 2007

Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. International Journal of Radiation Oncology, Biology, Physics 83(4): 1185-1191, 2012

Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. International Journal of Radiation Oncology, Biology, Physics 94(4): 747-754, 2016

Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology, Biology, Physics 97(4): 797-805, 2017

Correlation of Dose to Bone Marrow With Hematological Toxicity and Mri Based Estimation of Conversion of Active to Inactive Bone Marrow in Long Course Neo adjuvant Chemoradiation for Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics 93(3): E135-E136, 2015

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Management and Research Volume 11: 6285-6297, 2019

Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. International Journal of Radiation Oncology, Biology, Physics 79(4): 1043-1047, 2011

The volume of PET-defined, active bone marrow spared predicts acute hematologic toxicities in anal cancer patients receiving concurrent chemoradiotherapy. Acta Oncologica 57(5): 683-686, 2017

Bone Marrow Irradiation Predicts for Hematologic Toxicity in Patients Undergoing Chemoradiation for Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics 93(3): E164-E165, 2015

Predictors of acute hematologic toxicity attributable to palliative radiotherapy: Analysis of patient characteristics and bone marrow dose-volume parameters. Journal of BUON 23(1): 261-267, 2018

(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy. International Journal of Radiation Oncology, Biology, Physics 90(5): 1099-1107, 2015